Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Molecular & Cellular Oncology|June 17, 2016
Direct pharmacological assessment of clinically acquired models as a strategy to overcome resistance to tyrosine kinase inhibitorsCyril H BenesBMC Bioinformatics|February 20, 2019
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasetsArnaud Amzallag, Sridhar Ramaswamy, Cyril H BenesBiochimica Et Biophysica Acta|March 15, 2011
P2X(7) receptor antagonists display agonist-like effects on cell signaling proteinsLee Hedden, Cyril H Benes, Stephen P SoltoffCancer Research|July 13, 2017
APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR InhibitionRémi Buisson, Michael S Lawrence, Cyril H Benes, et al.Molecular Cell|September 15, 2015
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S PhaseRémi Buisson, Jessica L Boisvert, Cyril H Benes, et al.Science (New York, N.Y.)|June 29, 2019
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic featuresRémi Buisson, Adam Langenbucher, Danae Bowen, et al.Cell|April 27, 2005
The C2 domain of PKCdelta is a phosphotyrosine binding domainCyril H Benes, Ning Wu, Andrew E H Elia, et al.Nature Biotechnology|September 12, 2017
Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilitiesJohn D Lapek, Patricia Greninger, Robert Morris, et al.Scientific Reports|January 24, 2025
Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation eventsLi Chen, Iulian Pruteanu-Malinici, Anahita Dastur, et al.Pageof 11